RadNet EBITDA Margin 2012-2025 | RDNT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for RadNet (RDNT) over the last 10 years. The current EBITDA margin for RadNet as of December 31, 2025 is .
| RadNet EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $2.04B | $0.28B | 13.73% |
| 2025-09-30 | $1.97B | $0.27B | 13.81% |
| 2025-06-30 | $1.91B | $0.28B | 14.42% |
| 2025-03-31 | $1.87B | $0.28B | 15.14% |
| 2024-12-31 | $1.83B | $0.32B | 17.21% |
| 2024-09-30 | $1.77B | $0.31B | 17.48% |
| 2024-06-30 | $1.71B | $0.32B | 18.49% |
| 2024-03-31 | $1.66B | $0.30B | 18.03% |
| 2023-12-31 | $1.62B | $0.29B | 18.18% |
| 2023-09-30 | $1.58B | $0.29B | 18.53% |
| 2023-06-30 | $1.53B | $0.26B | 16.68% |
| 2023-03-31 | $1.48B | $0.25B | 16.77% |
| 2022-12-31 | $1.43B | $0.24B | 16.57% |
| 2022-09-30 | $1.38B | $0.22B | 15.66% |
| 2022-06-30 | $1.36B | $0.24B | 17.55% |
| 2022-03-31 | $1.34B | $0.24B | 18.18% |
| 2021-12-31 | $1.32B | $0.26B | 19.77% |
| 2021-09-30 | $1.29B | $0.27B | 21.16% |
| 2021-06-30 | $1.25B | $0.26B | 20.74% |
| 2021-03-31 | $1.11B | $0.23B | 20.52% |
| 2020-12-31 | $1.07B | $0.20B | 18.45% |
| 2020-09-30 | $1.07B | $0.20B | 18.48% |
| 2020-06-30 | $1.07B | $0.19B | 17.62% |
| 2020-03-31 | $1.17B | $0.21B | 17.85% |
| 2019-12-31 | $1.16B | $0.22B | 19.13% |
| 2019-09-30 | $1.11B | $0.18B | 16.11% |
| 2019-06-30 | $1.06B | $0.16B | 15.00% |
| 2019-03-31 | $1.02B | $0.13B | 13.20% |
| 2018-12-31 | $0.97B | $0.11B | 11.09% |
| 2018-09-30 | $0.95B | $0.12B | 13.01% |
| 2018-06-30 | $0.94B | $0.12B | 12.57% |
| 2018-03-31 | $0.93B | $0.12B | 12.43% |
| 2017-12-31 | $0.92B | $0.12B | 13.11% |
| 2017-09-30 | $0.91B | $0.12B | 12.94% |
| 2017-06-30 | $0.91B | $0.12B | 13.20% |
| 2017-03-31 | $0.90B | $0.11B | 12.58% |
| 2016-12-31 | $0.89B | $0.11B | 12.43% |
| 2016-09-30 | $0.88B | $0.11B | 12.10% |
| 2016-06-30 | $0.86B | $0.11B | 12.57% |
| 2016-03-31 | $0.84B | $0.11B | 13.27% |
| 2015-12-31 | $0.81B | $0.11B | 13.10% |
| 2015-09-30 | $0.78B | $0.11B | 13.74% |
| 2015-06-30 | $0.76B | $0.11B | 13.91% |
| 2015-03-31 | $0.73B | $0.11B | 15.07% |
| 2014-12-31 | $0.72B | $0.12B | 16.43% |
| 2014-09-30 | $0.71B | $0.12B | 16.20% |
| 2014-06-30 | $0.70B | $0.11B | 15.69% |
| 2014-03-31 | $0.70B | $0.11B | 15.16% |
| 2013-12-31 | $0.70B | $0.11B | 15.22% |
| 2013-09-30 | $0.68B | $0.10B | 15.06% |
| 2013-06-30 | $0.67B | $0.11B | 15.84% |
| 2013-03-31 | $0.66B | $0.11B | 16.44% |
| 2012-12-31 | $0.65B | $0.11B | 17.34% |
| 2012-09-30 | $0.64B | $0.12B | 19.00% |
| 2012-06-30 | $0.62B | $0.12B | 19.19% |
| 2012-03-31 | $0.60B | $0.12B | 19.73% |
| 2011-12-31 | $0.59B | $0.12B | 19.66% |
| 2011-09-30 | $0.55B | $0.11B | 20.73% |
| 2011-06-30 | $0.55B | $0.11B | 20.66% |
| 2011-03-31 | $0.54B | $0.11B | 19.89% |
| 2010-12-31 | $0.52B | $0.10B | 19.69% |
| 2010-09-30 | $0.54B | $0.11B | 20.07% |
| 2010-06-30 | $0.53B | $0.11B | 19.77% |
| 2010-03-31 | $0.52B | $0.10B | 19.50% |
| 2009-12-31 | $0.53B | $0.11B | 20.11% |
| 2009-09-30 | $0.52B | $0.09B | 17.34% |
| 2009-06-30 | $0.52B | $0.09B | 17.60% |
| 2009-03-31 | $0.51B | $0.09B | 18.13% |
| 2008-12-31 | $0.50B | $0.09B | 17.84% |
| 2008-09-30 | $0.47B | $0.08B | 16.07% |
| 2008-06-30 | $0.45B | $0.07B | 15.93% |
| 2008-03-31 | $0.43B | $0.07B | 15.97% |
| 2007-12-31 | $0.42B | $0.07B | 15.57% |
| 2007-09-30 | $0.26B | $0.04B | 15.71% |
| 2007-06-30 | $0.19B | $0.02B | 9.84% |
| 2007-03-31 | $0.13B | $0.01B | 3.97% |
| 2006-12-31 | $0.06B | $-0.01B | -11.67% |
| 2006-10-31 | $0.16B | $0.02B | 11.11% |
| 2006-09-30 | $0.16B | $0.03B | 15.63% |
| 2006-07-31 | $0.16B | $0.03B | 15.63% |
| 2006-06-30 | $0.16B | $0.03B | 15.72% |
| 2006-03-31 | $0.12B | $0.02B | 13.91% |
| 2006-01-31 | $0.11B | $0.01B | 10.00% |
| 2005-04-30 | $0.10B | $0.01B | 5.83% |
| 2005-01-31 | $0.10B | $0.01B | 5.77% |
| 2004-04-30 | $0.11B | $0.01B | 9.43% |
| 2004-01-31 | $0.11B | $0.01B | 8.57% |
| 2003-04-30 | $0.11B | $0.00B | 3.81% |
| 2003-01-31 | $0.10B | $0.01B | 6.73% |
| 2002-04-30 | $0.10B | $0.01B | 14.74% |
| 2002-01-31 | $0.09B | $0.02B | 20.69% |
| 2001-07-31 | $0.10B | $0.03B | 30.10% |
| 2001-01-31 | $0.07B | $0.02B | 29.58% |
| 2000-12-31 | $0.07B | $0.02B | 30.00% |
| 2000-09-30 | $0.09B | $0.02B | 17.78% |
| 2000-07-31 | $0.09B | $0.02B | 17.24% |
| 2000-06-30 | $0.08B | $0.01B | 16.67% |
| 2000-04-30 | $0.08B | $0.02B | 25.61% |
| 2000-01-31 | $0.06B | $0.02B | 25.42% |
| 1999-12-31 | $0.06B | $0.01B | 20.69% |
| 1999-09-30 | $0.07B | $0.01B | 11.43% |
| 1999-06-30 | $0.07B | $0.01B | 10.45% |
| 1999-03-31 | $0.06B | $0.01B | 10.94% |
| 1998-12-31 | $0.06B | $0.01B | 11.29% |
| 1998-09-30 | $0.06B | $0.01B | 11.67% |
| 1998-06-30 | $0.06B | $0.01B | 11.48% |
| 1998-03-31 | $0.06B | $0.01B | 11.29% |
| 1997-12-31 | $0.07B | $0.01B | 12.12% |
| 1997-09-30 | $0.07B | 0 | 0.00% |
| 1997-06-30 | $0.07B | $0.01B | 16.67% |
| 1997-03-31 | $0.06B | $0.02B | 37.10% |
| 1996-12-31 | $0.06B | $0.04B | 62.07% |
| 1996-09-30 | $0.05B | $0.05B | 90.74% |
| 1996-06-30 | $0.05B | $0.05B | 90.57% |
| 1996-03-31 | $0.05B | $0.05B | 88.46% |
| 1995-12-31 | $0.05B | $0.04B | 86.00% |
| 1995-09-30 | $0.05B | $0.04B | 83.33% |
| 1995-06-30 | $0.04B | $0.04B | 81.82% |
| 1995-03-31 | $0.04B | $0.03B | 82.50% |
| 1994-12-31 | $0.04B | $0.03B | 81.58% |
| 1994-09-30 | $0.04B | $0.03B | 80.56% |
| 1994-06-30 | $0.04B | $0.03B | 82.50% |
| 1994-03-31 | $0.05B | $0.05B | 84.91% |
| 1993-12-31 | $0.06B | $0.06B | 87.50% |
| 1993-09-30 | $0.08B | $0.07B | 89.33% |
| 1993-06-30 | $0.08B | $0.07B | 90.67% |
| 1993-03-31 | $0.06B | $0.06B | 90.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |